98 related articles for article (PubMed ID: 34246312)
1. Causal inference multiple imputation investigation of the impact of cannabinoids and other substances on ethnic differentials in US testicular cancer incidence.
Reece AS; Hulse GK
BMC Pharmacol Toxicol; 2021 Jul; 22(1):40. PubMed ID: 34246312
[TBL] [Abstract][Full Text] [Related]
2. Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends.
Reece AS; Hulse GK
Clin Pediatr (Phila); 2019 Sep; 58(10):1085-1123. PubMed ID: 31288542
[TBL] [Abstract][Full Text] [Related]
3. Prenatal Exposure to Tobacco and Cannabis in Six Race/Ethnicity Groups during the First Three Years after Legalization of Cannabis for Recreational Use in California.
Kharrazi M; Berger K; Pearl M; Li Y; DeGuzman J; Behniwal P; Morse A; Moskalenko I; Williams RJ; She J
Int J Environ Res Public Health; 2023 Dec; 21(1):. PubMed ID: 38276799
[TBL] [Abstract][Full Text] [Related]
4. Investigating Cannabis-Use Among Students Attending High Schools Within the Cherokee Nation Reservation 2017 and 2019.
Campbell JE; Chen S; Bailey A; Blair A; Comiford AL
J Community Health; 2024 Jun; 49(3):402-414. PubMed ID: 38066219
[TBL] [Abstract][Full Text] [Related]
5. Challenges for Clinical Cannabis and Cannabinoid Research in the United States.
Cooper ZD; Abrams DI; Gust S; Salicrup A; Throckmorton DC
J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):114-122. PubMed ID: 34850896
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids and synthetic cannabinoids as a cause of death: Trends and their healthcare implications.
Suriaga A; Tappen RM; Aston ER; Chiang-Hanisko L; Newman D
J Nurs Scholarsh; 2023 May; 55(3):623-636. PubMed ID: 36250599
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019.
Britch SC; Walsh SL; Vickers-Smith R; Babalonis S; Slavova S
Subst Use Misuse; 2023; 58(1):66-76. PubMed ID: 36453437
[No Abstract] [Full Text] [Related]
8. Management site and level of health care for cannabis- and synthetic cannabinoid-related poison control center cases involving older adults, 2016-2019.
Choi NG; DiNitto DM; Marti CN; Baker SD
Drug Chem Toxicol; 2022 Jul; 45(4):1739-1747. PubMed ID: 33406940
[TBL] [Abstract][Full Text] [Related]
9. Cannabis Use in Patients with Gastroparesis.
Saleem S; Tarar ZI; Aziz M; Alsamman MA; Tansel A; Abell TL
Cannabis Cannabinoid Res; 2023 Dec; 8(6):1100-1105. PubMed ID: 36067326
[No Abstract] [Full Text] [Related]
10. Proximity to Cannabis Retailers and Recent Cannabis Use among a Diverse Sample of California Adolescents.
Albers L; Rogers CJ; Steinberg J; Vos RO; Soto D; Lee R; Wu JS; Unger JB
Subst Use Misuse; 2024; 59(5):643-650. PubMed ID: 38115623
[No Abstract] [Full Text] [Related]
11. Cannabis and Cannabinoids in the Perioperative Period.
Lee BH; Sideris A; Ladha KS; Johnson RL; Wu CL
Anesth Analg; 2024 Jan; 138(1):16-30. PubMed ID: 35551150
[TBL] [Abstract][Full Text] [Related]
12. Assessing effects of Cannabis on various neuropathologies: A systematic review.
Pathak S; Jeyabalan JB; Liu K; Cook P; Lange B; Kim S; Nadar R; Ward K; Watts Alexander CS; Kumar A; Dua K; Moore T; Govindasamy J; Dhanasekaran M
J Ayurveda Integr Med; 2024 Jun; ():100911. PubMed ID: 38876946
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cannabis Use on Least Pain Scores Among African American and White Patients with Cancer Pain: A Moderation Analysis.
Meghani SH; Quinn R; Ashare R; Levoy K; Worster B; Naylor M; Chittams J; Cheatle M
J Pain Res; 2021; 14():3493-3502. PubMed ID: 34764689
[TBL] [Abstract][Full Text] [Related]
14. A proof-of-concept study testing the factor structure of the Stop Signal Task: overlap with substance use and mental health symptoms.
Sutherland Charvis JM; Vergara-Lopez C; Hernandez Valencia EM; Fernandez ME; Rozum W; Lopez-Vergara HI
Am J Drug Alcohol Abuse; 2024 Apr; ():1-9. PubMed ID: 38557256
[No Abstract] [Full Text] [Related]
15. Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.
Reece AS; Hulse GK
Front Psychiatry; 2023; 14():1182536. PubMed ID: 37854446
[TBL] [Abstract][Full Text] [Related]
16. Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.
Reece AS; Hulse GK
Front Psychiatry; 2023; 14():1182535. PubMed ID: 37732074
[TBL] [Abstract][Full Text] [Related]
17. Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.
Reece AS; Bennett K; Hulse GK
J Xenobiot; 2023 Jul; 13(3):323-385. PubMed ID: 37489337
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and Paternal Epigenetic Inheritance.
Mazzeo F; Meccariello R
Int J Environ Res Public Health; 2023 Apr; 20(9):. PubMed ID: 37174181
[TBL] [Abstract][Full Text] [Related]
19. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
